Redwood Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-77,345
Closed -$6.33M 136
2021
Q2
$6.33M Sell
77,345
-425
-0.5% -$34.8K 0.51% 65
2021
Q1
$7.4M Sell
77,770
-68,893
-47% -$6.55M 0.65% 57
2020
Q4
$9.1M Sell
146,663
-21,296
-13% -$1.32M 0.77% 55
2020
Q3
$9.99M Sell
167,959
-9,475
-5% -$563K 0.84% 56
2020
Q2
$12.4M Buy
+177,434
New +$12.4M 1.09% 44
2019
Q3
Sell
-240,107
Closed -$17.1M 137
2019
Q2
$17.1M Sell
240,107
-4,718
-2% -$336K 1.26% 27
2019
Q1
$19.2M Buy
244,825
+66,466
+37% +$5.21M 1.4% 17
2018
Q4
$15.1M Buy
178,359
+68,235
+62% +$5.78M 1.42% 18
2018
Q3
$18.9M Sell
110,124
-34,553
-24% -$5.92M 1.47% 12
2018
Q2
$18.7M Sell
144,677
-8,900
-6% -$1.15M 1.29% 29
2018
Q1
$15.8M Buy
153,577
+9,711
+7% +$1M 1.13% 39
2017
Q4
$12.3M Buy
143,866
+44,706
+45% +$3.82M 0.87% 57
2017
Q3
$8.42M Sell
99,160
-14,347
-13% -$1.22M 0.96% 42
2017
Q2
$8.6M Buy
113,507
+10,978
+11% +$831K 0.87% 56
2017
Q1
$6.77M Buy
102,529
+314
+0.3% +$20.7K 0.67% 77
2016
Q4
$6.48M Buy
102,215
+586
+0.6% +$37.1K 0.59% 81
2016
Q3
$6.47M Buy
101,629
+54,430
+115% +$3.47M 0.49% 76
2016
Q2
$3.51M Sell
47,199
-14,007
-23% -$1.04M 0.32% 86
2016
Q1
$4.09M Buy
61,206
+31,135
+104% +$2.08M 0.41% 60
2015
Q4
$2.03M Buy
30,071
+4,654
+18% +$315K 0.22% 78
2015
Q3
$1.36M Sell
25,417
-30,481
-55% -$1.63M 0.18% 85
2015
Q2
$3.52M Buy
55,898
+18,787
+51% +$1.18M 0.44% 53
2015
Q1
$1.79M Buy
37,111
+11,907
+47% +$573K 0.29% 72
2014
Q4
$837K Sell
25,204
-5,218
-17% -$173K 0.13% 93
2014
Q3
$892K Buy
30,422
+1,332
+5% +$39.1K 0.12% 93
2014
Q2
$1.13M Buy
29,090
+6,068
+26% +$236K 0.14% 91
2014
Q1
$966K Buy
+23,022
New +$966K 0.14% 92